サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1402484

欧州の左室補助人工心臓市場の2028年までの予測- 地域別分析- フロータイプ、設計、用途別

Europe Left Ventricular Assist Device Market Forecast to 2028 - Regional Analysis - by Type of Flow, Design, and Application
出版日: | 発行: The Insight Partners | ページ情報: 英文 129 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
欧州の左室補助人工心臓市場の2028年までの予測- 地域別分析- フロータイプ、設計、用途別
出版日: 2023年10月26日
発行: The Insight Partners
ページ情報: 英文 129 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

欧州の左室補助人工心臓市場は、2022年の3億3,652万米ドルから2028年には4億4,505万米ドルに成長すると予測されています。2022年から2028年までのCAGRは4.8%で成長すると推定されています。

LVADにおける人工知能と機械学習の使用の増加が欧州の左室補助人工心臓市場を牽引

LVADに関連する合併症や有害事象の発生率の増加は、メーカーが革新的な技術を開発し、新しい技術を機器に統合することを促しました。LVADを装着した患者が右心室不全に陥り、静脈に血液が溜まって腫れるケースがいくつかあります。このような障害を減らすために、メーカーは人工知能（AI）を組み込んでLVADで右心室をモニターしています。そのため、右心室の活動や機能に変化があれば医療従事者に報告され、右心室不全や合併症の可能性を減らすことができます。

さらに、心不全死亡のリスクスコアを開発するための機械学習（ML）の使用が増加しているため、従来の方法よりも優位性があります。さらに、ウェアラブルデバイスからの遠隔測定データ分析は、心不全による入院の予測に役立ちます。機械学習アルゴリズムは、2Dおよび3D心エコー検査で三尖弁輪の伸展にアクセスするために使用され、右室機能の評価に役立っています。さらに、機械学習ベースのアルゴリズムは、3D心エコー画像を用いて右室容積と駆出率を調べ、正確なデータと心機能の効率的な自動分析を提供します。

したがって、人工知能と機械学習アルゴリズムの使用は、LVADを装着した末期心不全患者の右室機能に基づくリスク予測モデルの開発に役立ちます。右室不全のリスク層別化は患者の生存を決定する重要な因子の一つです。したがって、LVADにおける人工知能と機械学習の使用は、予測期間中に左心室補助装置（LVAD）市場の主要動向として浮上する可能性が高いです。

欧州の左室補助人工心臓市場概要

英国議会のデータによると、2019年には英国総人口の約5分の1が65歳以上となっています。さらに、この年齢層の人口は2009年から2019年にかけて23%増加したが、同期間の英国総人口は7%しか増加していないです。65歳以上の人々は、心血管疾患や心不全にかかりやすいです。心不全の有病率の増加に伴い、英国では心臓移植の待機リストが長くなっています。英国心臓財団（British Heart Foundation）の調査によると、英国では2019年に～300人がLVADとともに生活しているが、2012年には～100人しかLVADとともに生活していなかった。英国老年医学会（British Geriatrics Society）が提供したデータによると、2020年には英国で～100万人が心不全を抱え、緊急入院した人の～5％が心不全を患っていました。2020年には、国民保健サービス（NHS）総支出の～2％が心不全治療に費やされます。心不全の有病率の急増が英国のLVAD市場の成長を促進しています。

欧州の左心室補助装置市場の収益と2028年までの予測（金額）

欧州の左心室補助装置市場のセグメンテーション

欧州の左室補助人工心臓市場は、流れのタイプ、デザイン、用途、国別に区分されます。

流れのタイプに基づいて、欧州の左室補助人工心臓市場は拍動性流れと非拍動性流れに二分されます。2022年、欧州の左室補助人工心臓市場では、非脈動流分野がより大きなシェアを記録しました。

デザインに基づくと、欧州の左室補助人工心臓市場は植え込み型補助循環装置と経皮的補助循環装置に二分されます。2022年には、植え込み型補助人工心臓分野が欧州左心室補助装置市場でより大きなシェアを記録しました。

用途別では、欧州の左室補助装置市場は、移植への橋渡し、目的地治療、回復への橋渡し、候補地への橋渡しに区分されます。2022年、欧州の左室補助人工心臓市場では、目的地治療分野が最大のシェアを記録しました。

国別に見ると、欧州の左室補助人工心臓市場は、英国、ドイツ、フランス、イタリア、スペイン、その他欧州に区分されます。2022年、英国は欧州の左室補助人工心臓市場で最大のシェアを記録しました。

Abbott Laboratories、Medtronic Plc、Evaheart Inc.、CorWave SAは、欧州の左室補助人工心臓市場で事業を展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 キーポイント

第3章 調査手法

  • カバー範囲
  • 2次調査
  • 1次調査

第4章 欧州の左室補助人工心臓市場- 市場展望

  • 概観
  • 欧州PEST分析
  • 専門家の見解

第5章 欧州の左室補助人工心臓市場：主要市場力学

  • 市場促進要因
    • 対象疾患および手技の発生率の増加
    • 老年人口の増加
  • 市場抑制要因
    • 左室補助人工心臓のリコールおよび合併症の増加
  • 市場機会
    • 新興経済国の未開発可能性
  • 今後の動向
    • LVADにおける人工知能と機械学習の利用の増加
  • 影響分析

第6章 左室補助人工心臓市場：欧州分析

  • 欧州の左室補助人工心臓市場収益と予測分析

第7章 欧州の左室補助人工心臓市場分析：フロータイプ別

  • 拍動性フロー
  • 非拍動性

第8章 欧州の左室補助人工心臓市場分析：デザイン別

  • 植込み型補助人工心臓
  • 経皮的補助人工心臓

第9章 欧州の左室補助人工心臓市場分析：用途別

  • BTT
  • DT
  • BTR
  • BTC

第10章 欧州の左室補助人工心臓市場の収益と2028年までの予測：国別分析

  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • その他欧州

第11章 企業プロファイル

  • ABIOMED Inc
  • Medtronic Plc
  • Evaheart Inc
  • CorWave SA

第12章 付録

図表

List Of Tables

  • Table 1. UK: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
  • Table 2. UK: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. UK: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Germany: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Germany: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Germany: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. France: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. France: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. France: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Italy: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Italy: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Italy: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Spain: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Spain: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Spain: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Rest of Europe: Left Ventricular Assist Device Market, by Type of Flow - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Rest of Europe: Left Ventricular Assist Device Market, by Design - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Rest of Europe: Left Ventricular Assist Device Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Glossary of Terms

List Of Figures

  • Figure 1. Europe Left Ventricular Assist Device Market Segmentation
  • Figure 2. Europe Left Ventricular Assist Device Market, By Country
  • Figure 3. Europe Left Ventricular Assist Device Market Overview
  • Figure 4. Implantable Ventricular Assist Device Held Largest Share for Design Segment in Europe Left Ventricular Assist Device Market
  • Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 7. Europe: PEST Analysis
  • Figure 8. Experts Opinion
  • Figure 9. Impact Analysis
  • Figure 10. Europe Left Ventricular Assist Device Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 11. Europe Left Ventricular Assist Device Market, by Type of Flow 2021 & 2028 (%)
  • Figure 12. Pulsatile Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 13. Non-Pulsatile Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 14. Europe Left Ventricular Assist Device Market, by Design 2021 & 2028 (%)
  • Figure 15. Implantable Ventricular Assist Devices Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 16. Transcutaneous Ventricular Assist Devices Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 17. Europe Left Ventricular Assist Device Market, by Application 2021 & 2028 (%)
  • Figure 18. Bridge to Transplantation Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 19. Destination Therapy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 20. Bridge to Recovery Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 21. Bridge to Candidacy Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 22. Europe: Left Ventricular Assist Device Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 23. Europe: Left Ventricular Assist Device Market, by Country, 2021 & 2028 (%)
  • Figure 24. UK: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Germany: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. France: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Italy: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Spain: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Rest of Europe: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00029021

The Europe left ventricular assist device market is expected to grow from US$ 336.52 million in 2022 to US$ 445.05 million by 2028. It is estimated to grow at a CAGR of 4.8% from 2022 to 2028.

Increased Use of Artificial Intelligence and Machine Learning in LVAD Drive Europe Left Ventricular Assist Device Market

The increased incidence of complications and adverse events associated with LVAD encouraged manufacturers to develop innovative technologies and integrate new technologies into the devices. In several cases, patients with LVAD devices experience right ventricle failure leading to blood buildup in veins and swelling. To reduce the failure, manufacturers have integrated artificial intelligence (AI) to monitor the right ventricle with LVAD. Therefore, any change in the right ventricle activity and function will be reported to the healthcare professional, reducing the chances of right ventricle failure and complications.

Furthermore, the increased use of machine learning (ML) for developing risk scores for heart failure mortality provides an edge over conventional methods. Additionally, telemetry data analysis from wearable devices helps predict heart failure hospitalizations. Machine learning algorithms are used to access tricuspid annulus excursion on 2D and 3D echocardiography, which helps in the assessment of right ventricle function. Moreover, machine learning-based algorithms use 3D echocardiographic images to study the right ventricle volume and ejection fraction, providing exact data and efficient automated analysis of heart function.

Therefore, the use of artificial intelligence and machine learning algorithms helps develop a risk prediction model based on right ventricle functions in end-stage heart failure patients with LVAD. The risk stratification for right ventricle failure is one of the significant factors that help determine the patients' survival. Therefore, the use of artificial intelligence and machine learning in LVAD is likely to emerge as a key trend in the left ventricle assist devices (LVAD) market during the forecast period.

Europe Left Ventricular Assist Device Market Overview

According to the UK Parliament's data, approximately one-fifth of the total UK population was aged 65 and above in 2019. Moreover, the number of people in this age group increased by 23% from 2009 to 2019, while the total UK population increased by only 7% during the same period. People aged 65 or above are highly prone to cardiovascular diseases and heart failure. With the increasing prevalence of heart failure, the waiting list for heart transplantation is long in the UK. According to a study by the British Heart Foundation, ~300 people were living with LVAD in the UK in 2019, while only ~100 people were living with LVAD in 2012. According to the data provided by the British Geriatrics Society, in 2020, ~1 million people in the UK were living with heart failure, and ~5% of the people admitted to hospitals for emergencies were suffering from heart failure. In 2020, ~2% of the total National Health Service (NHS) expenditure is spent on treatment of heart failure. A surge in the prevalence of heart failure is propelling the growth of the LVAD market in the UK.

Europe Left Ventricular Assist Device Market Revenue and Forecast to 2028 (US$ Million)

Europe Left Ventricular Assist Device Market Segmentation

The Europe left ventricular assist device market is segmented into type of flow, design, application, and country.

Based on type of flow, the Europe left ventricular assist device market is bifurcated into pulsatile flow and non-pulsatile flow. In 2022, the non-pulsatile flow segment registered a larger share in the Europe left ventricular assist device market.

Based on design, the Europe left ventricular assist device market is bifurcated into implantable ventricular assist devices and transcutaneous ventricular assist devices. In 2022, the implantable ventricular assist devices segment registered a larger share in the Europe left ventricular assist device market.

Based on application, the Europe left ventricular assist device market is segmented into Bridge to transplantation, destination therapy, bridge to recovery, and bridge to candidacy. In 2022, the destination therapy segment registered the largest share in the Europe left ventricular assist device market.

Based on country, the Europe left ventricular assist device market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. In 2022, the UK registered the largest share in the Europe left ventricular assist device market.

Abbott Laboratories, Medtronic Plc, Evaheart Inc., and CorWave SA are some of the leading companies operating in the Europe left ventricular assist device market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe left ventricular assist device market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe left ventricular assist device market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the left ventricular assist device market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Europe Left Ventricular Assist Device Market - By Type of Flow
    • 1.3.2 Europe Left Ventricular Assist Device Market - By Design
    • 1.3.3 Europe Left Ventricular Assist Device Market - By Application
    • 1.3.4 Europe Left Ventricular Assist Device Market - By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Left Ventricular Assist Device Market - Market Landscape

  • 4.1 Overview
  • 4.2 Europe PEST Analysis
  • 4.3 Experts Opinion

5. Europe Left Ventricular Assist Device Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidence of Target Diseases and Procedures
    • 5.1.2 Growing Geriatric Population
  • 5.2 Market Restraints
    • 5.2.1 Increase in Product Recalls and Complications Associated with Left Ventricular Assist Devices
  • 5.3 Market Opportunities
    • 5.3.1 Untapped Potential of Emerging Economies
  • 5.4 Future Trends
    • 5.4.1 Increased Use of Artificial Intelligence and Machine Learning in LVAD
  • 5.5 Impact Analysis

6. Left Ventricular Assist Device Market - Europe Analysis

  • 6.1 Europe Left Ventricular Assist Device Market Revenue Forecast & Analysis

7. Europe Left Ventricular Assist Device Market Analysis - By Type of Flow

  • 7.1 Overview
  • 7.2 Europe Left Ventricular Assist Device Market, By Type of Flow 2021 & 2028 (%)
  • 7.3 Pulsatile Flow
    • 7.3.1 Overview
    • 7.3.2 Pulsatile Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Non-Pulsatile
    • 7.4.1 Overview
    • 7.4.2 Non-Pulsatile Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Left Ventricular Assist Device Market Analysis - By Design

  • 8.1 Overview
  • 8.2 Europe Left Ventricular Assist Device Market, By Design 2021 & 2028 (%)
  • 8.3 Implantable Ventricular Assist Devices
    • 8.3.1 Overview
    • 8.3.2 Implantable Ventricular Assist Devices Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Transcutaneous Ventricular Assist Devices
    • 8.4.1 Overview
    • 8.4.2 Transcutaneous Ventricular Assist Devices Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Left Ventricular Assist Device Market - By Application

  • 9.1 Overview
  • 9.2 Europe Left Ventricular Assist Device Market, By Application 2021 & 2028 (%)
  • 9.3 Bridge to Transplantation
    • 9.3.1 Overview
    • 9.3.2 Bridge to Transplantation Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Destination Therapy
    • 9.4.1 Overview
    • 9.4.2 Destination Therapy Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Bridge to Recovery
    • 9.5.1 Overview
    • 9.5.2 Bridge to Recovery Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Bridge to Candidacy
    • 9.6.1 Overview
    • 9.6.2 Bridge to Candidacy Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Left Ventricular Assist Device Market Revenue and Forecasts to 2028 - Country Analysis

  • 10.1 Overview
    • 10.1.1 Europe: Left Ventricular Assist Device Market, by Country, 2021 & 2028 (%)
      • 10.1.1.1 UK: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 UK: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.1.3 UK: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.1.1.4 UK: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.1.1.5 UK: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
      • 10.1.1.2 Germany: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Germany: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.2.3 Germany: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.1.2.4 Germany: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.1.2.5 Germany: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
      • 10.1.1.3 France: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.3.3 France: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.1.3.4 France: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.1.3.5 France: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
      • 10.1.1.4 Italy: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.4.3 Italy: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.1.4.4 Italy: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.1.4.5 Italy: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
      • 10.1.1.5 Spain: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.5.3 Spain: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.1.5.4 Spain: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.1.5.5 Spain: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)
      • 10.1.1.6 Rest of Europe: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Europe: Left Ventricular Assist Device Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.1.6.3 Rest of Europe: Left Ventricular Assist Device Market, by Type of Flow, 2019-2028 (US$ Million)
        • 10.1.1.6.4 Rest of Europe: Left Ventricular Assist Device Market, by Design, 2019-2028 (US$ Million)
        • 10.1.1.6.5 Rest of Europe: Left Ventricular Assist Device Market, by Application, 2019-2028 (US$ Million)

11. COMPANY PROFILES

  • 11.1 ABIOMED Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Medtronic Plc
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Evaheart Inc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 CorWave SA
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms